This inventor holds 1 USPTO granted patent. Top assignee: Tasly Pharmaceutical Group Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yanmei Li and a Pharmaceutical Composition for Myocardial Ischemia
Introduction
Yanmei Li is a woman inventor associated with Tianjin, China, and Tasly Pharmaceutical Group Co., Ltd. Her listed patent concerns a pharmaceutical composition intended to prevent or treat myocardial ischemia.
Latest Patents
The provided information lists 1 patent for Yanmei Li: “Pharmaceutical Composition for Treating Myocardial Ischemia and Preparation Method Therefor.” The invention describes a composition containing 250–700 parts by weight of Salvia miltiorrhiza medicinal material, 50–150 parts of Radix notoginseng medicinal material, 3–9 parts of synthetic borneol, and 25–100 parts of ranolazine. It also describes using the composition to prepare a medicine for the prevention and/or treatment of myocardial ischemia.
Career Highlights
The available details associate Li with Tasly Pharmaceutical Group Co., Ltd. and identify her work on a patent combining traditional medicinal materials with ranolazine for a cardiovascular application.
Collaborations
The supplied information names He Sun and Kaijing Yan as Li’s coworkers. It does not specify their roles or the nature of their collaboration on the patent.
Conclusion
Yanmei Li’s listed patent focuses on a multi-ingredient pharmaceutical composition and its potential use in preventing or treating myocardial ischemia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile